spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Pharmaceutical companies go temporary to overcome pandemic challenges

Aggreko

Temporary equipment can help pharmaceutical companies amid the COVID-19 pandemic

Fast-tracking clinical trials, optimising energy intensive processes and improving yield are three ways in which temporary equipment is helping pharmaceutical companies amid the COVID-19 pandemic.

As well as it having a catastrophic effect on the global economy, COVID-19 has mounted pressure on critical industries, such as pharmaceutical, to respond quickly while diversifying their operations.

“Managers from all types of pharmaceutical companies urgently require new ways to make processes more efficient, so they can achieve more in less time,” explains Brian Gray, Pharmaceutical Sector Manager at Aggreko Northern Europe.

The need to get clinical trials up and running quickly has been exacerbated by the pandemic. However, responsibility for these research projects often falling to start-up companies with restricted budgets, meaning obtaining the latest equipment is challenging.

“We are seeing more companies turn to strategic hire projects at this time as they just simply do not have the existing infrastructure in place to conduct the required level of trials,” says Brian. “At the same time, they are having to keep up with existing demand and navigate supply shortages.”

In terms of getting new medicines into production, ageing facilities are also hampering progress. The fast-changing nature of the industry also means equipment demand can change every day.

Brian continues: “We know UK manufacturing struggles as a whole with ageing equipment, but in a sector that progresses at such pace there needs to be a more adaptable solution. The pandemic has simply compounded that issue.”

Aggreko is working with processing industries such as pharmaceutical, petrochemical and food & beverage to help assess their current processes and identify new ways in which companies can do more with less.

“We have access to the latest technology in power generation, temperature control and decentralised energy, which can help solve many of the problems industry are facing,” Brian concludes. “The main attraction is that there is no capex required and it also negates the need for additional skills on site. Many businesses are already realising the benefits, so we’re glad we can help.”

For more information on how to improve efficiency in the pharmaceutical industry following the COVID-19 pandemic and Aggreko’s latest ‘Hire Efficiency Expectations’ campaign, visit: https://www.aggreko.com/en-gb/news/2020/noeur-articles/hire-efficiency-blog-pharmaceutical
phone 0333 016 2068
web https://www.aggreko.com/en
email Aggreko Sutton, Kimpton Industrial Estate, 14 Sandiford Rd, Sutton, SM3 9RD
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Merck to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics

• Collaboration to accelerate development and manufacturing of Bispecific Antibody • Merck plans to offer Phanes a full suite of products and services under its BioReliance® offering
More info >>


White Papers

Nasal Drug Delivery with a Focus on Chronic Rhino-Sinusitis

Aptar Pharma

Aptar Pharma have hosted a scientific roundtable on “Nasal drug delivery with a focus on chronic rhino‑sinusitis”. This international scientific forum was held in Paris, France on November 13th 2012. The roundtable was organized to explore and exchange views on the science of various forms of sinusitis and its related unmet medical needs.
More info >>

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement